Hepatitis C virus (HCV) infection is a significant cause of morbidity and mortality in
hemodialysis (HD) patients. The reported prevalence of HCV among the HD population has …

Background Hepatitis C virus (HCV) outbreaks among patients on hemodialysis are still an
important health concern all over the world. Aims We performed a systematic review of …

Some people who are receiving dialysis treatment have virus infection such as hepatitis B,
hepatitis C and/or HIV that is present in their blood. These infections can be transmitted to …

Prevention of nosocomial transmission of hepatitis B virus (HBV) has been a signal
achievement in the management of chronic kidney disease. The rate of serum hepatitis B …

In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

Die Überarbeitung der 2004 publizierten S3-Leitlinie über „Prophylaxe, Diagnostik und
Therapie der Hepatitis-C-Virus (HCV)-Infektion “wurde vereinbart als Kooperation der …

Hemodialysis patients are at an increased risk of acquiring hepatitis B virus (HBV) and
hepatitis C virus (HCV) infection. However, the prevalence of hepatitis viral infection and its …

Background Changes in the delivery of healthcare in the developed world have resulted in
frequent reporting of outbreaks of hepatitis B virus (HBV) infection in nonhospital healthcare …

Summary Background Healthcare-associated infections (HCAIs) cause significant morbidity
and mortality worldwide, and outbreaks are often only identified after they reach high levels …

Kidney Disease: Improving Global Outcomes (KDIGO) recently published evidence-based
clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of …